[Effect of Qianlie Huazhuo Capsule for treatment of chronic prostatitis of dampness-heat stagnancy type].
To evaluate the therapeutic effects of Qianlie Huazhuo Capsule (QHC) on patients with chronic prostatitis of dampness-heat stagnancy type (CP-DHS). Sixty-five patients were randomly assigned to the treatment group (32 cases) treated with QHC and the control group (33 cases) treated with Qianlie Jiedu Capsule, for 1 month respectively. The clinical efficacy was evaluated at the end of the 2nd and 4th month, their quality of life (QOL) was estimated by NIH Chronic Prostatitis Syndrome Index (NIH-CPSI) and patients' capacity was estimated by SF-12 scale as well. Out of patients in the treatment group, 2 got cured, notable effect showed in 15, effective in 9, and ineffective in 6, the total effective rate being 81.2%, while in the 33 patients of the control group, 2 got cured, notable effect in 5, effective in 13 and ineffective in 13, the total effective rate 60.6%, the difference between the two groups was statistically significant in the total efficacy (P < 0.05). As compared with the control group, the NIH-CPSI score for QOL was significantly lower, SF-12 physical capacity score was better in the treatment group (both P < 0.05), and SF-12 mental capacity score in the two groups showed insignificant difference. QHC could obtain good effect for the treatment of CP-DHS.